Research Letter: Unmet Need for Hypertension Treatment in India: Evidence from Hypertension Drugs Market Data.
作者信息
Pathni Anupam Khungar, Sahoo Swagata Kumar, Moran Andrew E, Cohn Jennifer, Bhatia Sanchit, Maheshwari Nilesh, Sharma Bhawna
机构信息
Resolve to Save Lives, an initiative of Vital Strategies, New York, US.
Columbia University Irving Medical Center, New York, US.
出版信息
Glob Heart. 2021 Apr 23;16(1):26. doi: 10.5334/gh.973.
Abstract
摘要
相似文献
1
Research Letter: Unmet Need for Hypertension Treatment in India: Evidence from Hypertension Drugs Market Data.研究信函：印度高血压治疗需求未得到满足：来自高血压药物市场数据的证据。
Glob Heart. 2021 Apr 23;16(1):26. doi: 10.5334/gh.973.
2
Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016-2018.研究快报：印度抗高血压药物市场：2016-2018 年私营医疗领域的规模、趋势和处方偏好洞察
Glob Heart. 2021 Aug 2;16(1):51. doi: 10.5334/gh.999. eCollection 2021.
3
Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study.孟加拉国和印度老年人高血压的患病率、知晓率、治疗率及控制率：一项多中心研究
Bull World Health Organ. 2001;79(6):490-500.
4
Strategies for initial management of hypertension.高血压的初始管理策略。
Indian J Med Res. 2010 Nov;132(5):531-42.
5
Reply to letter to the editor titled: Generalizability of hypertension risk factors and achieving blood pressure control in educator populations in India.对致编辑的信的回复，信的标题为：印度教育工作者群体中高血压危险因素的普遍性及血压控制情况
Indian Heart J. 2021 Mar-Apr;73(2):255. doi: 10.1016/j.ihj.2021.01.001. Epub 2021 Jan 7.
6
Convergence in urban-rural prevalence of hypertension in India.印度城乡高血压患病率的趋同情况。
J Hum Hypertens. 2016 Feb;30(2):79-82. doi: 10.1038/jhh.2015.48. Epub 2015 Jun 25.
7
New Drugs and Interventional Strategies for the Management of Hypertension.高血压管理的新药与介入策略
Curr Pharm Des. 2021;27(11):1396-1406. doi: 10.2174/1381612826666201106091527.
8
Awareness, treatment adherence and risk predictors of uncontrolled hypertension at a tertiary care teaching hospital in Western India.印度西部一家三级护理教学医院中未控制高血压的知晓率、治疗依从性及风险预测因素
Indian Heart J. 2016 Sep;68 Suppl 2(Suppl 2):S251-S252. doi: 10.1016/j.ihj.2016.08.003. Epub 2016 Aug 21.
9
A retrospective analysis of hypertension screening at a mass gathering in India: implications for non-communicable disease control strategies.印度一次大型集会中高血压筛查的回顾性分析：对非传染性疾病控制策略的启示
J Hum Hypertens. 2017 Nov;31(11):750-753. doi: 10.1038/jhh.2017.54. Epub 2017 Jul 20.
10
Impact of Coming Demographic Changes on the Number of Adults in Need of Care for Hypertension in Brazil, China, India, Indonesia, Mexico, and South Africa.人口结构变化对巴西、中国、印度、印度尼西亚、墨西哥、南非需要护理的高血压成年人数量的影响。
Hypertension. 2019 Apr;73(4):770-776. doi: 10.1161/HYPERTENSIONAHA.118.12337.
引用本文的文献
1
Hypertension control rate in India: systematic review and meta-analysis of population-level non-interventional studies, 2001-2022.印度的高血压控制率：2001年至2022年人群水平非干预性研究的系统评价与荟萃分析
Lancet Reg Health Southeast Asia. 2022 Nov 23;9:100113. doi: 10.1016/j.lansea.2022.100113. eCollection 2023 Feb.
2
Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016-2018.研究快报：印度抗高血压药物市场：2016-2018 年私营医疗领域的规模、趋势和处方偏好洞察
Glob Heart. 2021 Aug 2;16(1):51. doi: 10.5334/gh.999. eCollection 2021.
本文引用的文献
1
Prescription Pattern of Antihypertensive Drugs: An Experience from a Secondary Care Hospital in the United Arab Emirates.抗高血压药物的处方模式：来自阿联酋一家二级护理医院的经验
J Res Pharm Pract. 2019 Apr-Jun;8(2):92-100. doi: 10.4103/jrpp.JRPP_18_85.
2
Hypertension screening, awareness, treatment, and control in India: A nationally representative cross-sectional study among individuals aged 15 to 49 years.印度的高血压筛查、知晓率、治疗和控制情况：一项针对 15 至 49 岁人群的全国代表性横断面研究。
PLoS Med. 2019 May 3;16(5):e1002801. doi: 10.1371/journal.pmed.1002801. eCollection 2019 May.
3
Emerging trends in hypertension epidemiology in India.印度高血压流行病学的新兴趋势。
J Hum Hypertens. 2019 Aug;33(8):575-587. doi: 10.1038/s41371-018-0117-3. Epub 2018 Sep 25.
4
Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults.印度的糖尿病和高血压：一项涉及 130 万成年人的全国代表性研究。
JAMA Intern Med. 2018 Mar 1;178(3):363-372. doi: 10.1001/jamainternmed.2017.8094.
5
Availability of medicines in public sector health facilities of two North Indian States.印度北部两个邦的公共部门卫生机构的药品供应情况。
BMC Pharmacol Toxicol. 2015 Dec 23;16:43. doi: 10.1186/s40360-015-0043-8.
6
Essential Medicines: An Indian Perspective.基本药物：印度视角
Indian J Community Med. 2015 Oct-Dec;40(4):223-32. doi: 10.4103/0970-0218.164382.
7
Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension.印度的高血压：高血压患病率、知晓率及控制率的系统评价与荟萃分析
J Hypertens. 2014 Jun;32(6):1170-7. doi: 10.1097/HJH.0000000000000146.
8
Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?规定日剂量与定义日剂量之间的差异：是患者的问题还是药物类别的问题？
Eur J Clin Pharmacol. 2011 Aug;67(8):847-54. doi: 10.1007/s00228-011-1014-7. Epub 2011 Mar 10.
Zotero 插件